| Product Code: ETC7539762 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India chimeric antigen receptor (CAR) T-cell therapy market import shipments experienced a declining trend with a negative CAGR from 2020 to 2024. The growth rate between 2023 and 2024 further decreased significantly, indicating a notable slowdown in market expansion during the latter period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market - Industry Life Cycle |
3.4 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market - Porter's Five Forces |
3.5 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume Share, By Drug type, 2021 & 2031F |
3.6 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in India |
4.2.2 Growing investments in healthcare infrastructure |
4.2.3 Rising adoption of personalized medicine in cancer treatment |
4.3 Market Restraints |
4.3.1 High costs associated with CAR-T cell therapy |
4.3.2 Limited reimbursement policies for CAR-T cell therapy in India |
4.3.3 Lack of awareness and understanding among healthcare professionals and patients |
5 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Trends |
6 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, By Types |
6.1 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, By Drug type |
6.1.1 Overview and Analysis |
6.1.2 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Drug type, 2021- 2031F |
6.1.3 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Axicabtagene Ciloleucel, 2021- 2031F |
6.1.4 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Tisagenlecleucel, 2021- 2031F |
6.1.5 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Brexucabtagene Autoleucel, 2021- 2031F |
6.1.6 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.2.3 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Acute Lymphocytic Leukemia, 2021- 2031F |
6.2.4 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenues & Volume, By Cancer Treatment Centers, 2021- 2031F |
7 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Import-Export Trade Statistics |
7.1 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Export to Major Countries |
7.2 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Imports from Major Countries |
8 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Key Performance Indicators |
8.1 Number of clinical trials and research studies on CAR-T cell therapy in India |
8.2 Percentage of cancer patients opting for CAR-T cell therapy in India |
8.3 Rate of approval and adoption of CAR-T cell therapy by regulatory bodies in India |
9 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market - Opportunity Assessment |
9.1 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Opportunity Assessment, By Drug type, 2021 & 2031F |
9.2 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Opportunity Assessment, By End user, 2021 & 2031F |
10 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market - Competitive Landscape |
10.1 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue Share, By Companies, 2024 |
10.2 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here